Explanation

Early refill requests for Schedule II controlled substances require a careful, systematic clinical response. The PMHNP should conduct a thorough clinical assessment including current symptoms, signs of intoxication or withdrawal, and evaluation for substance misuse. Checking the PDMP is essential to identify any concerning patterns. If a replacement prescription is clinically indicated, a limited supply with closer follow-up reduces risk while meeting the patient's needs. Thorough documentation should include the patient's report, clinical assessment findings, PDMP results, clinical reasoning, and the plan going forward. Setting clear expectations about future refills and establishing a policy (e.g., requiring a police report for future incidents) helps manage risk longitudinally.

Key Takeaway

Early refill requests require clinical assessment and PDMP checking.